Xlife Sciences AG
SIX:XLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Domo Inc
NASDAQ:DOMO
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its Industry Average (20.7), the stock would be worth CHf-0.56 (103% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -760.3 | CHf20.7 |
0%
|
| Industry Average | 20.7 | CHf-0.56 |
-103%
|
| Country Average | 16.1 | CHf-0.44 |
-102%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CH |
|
Xlife Sciences AG
SIX:XLS
|
118.9m CHF | -760.3 | 3.9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 1 774.1 | 4 280.5 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
193.4B USD | 27.8 | 28.8 | |
| US |
|
Danaher Corp
NYSE:DHR
|
130.1B USD | 22.5 | 36 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 36.2 | 46.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.9B CHF | 32.3 | -123.8 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
296.1B CNY | 15.3 | 15.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.1B USD | 25.5 | 26.4 | |
| US |
|
Waters Corp
NYSE:WAT
|
32.8B USD | 50.8 | 51 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.7B USD | 15.7 | 22 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.7B USD | 30 | 30.7 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 16.1 |
| 70th Percentile | 20.8 |
| Max | 647 |
Other Multiples
Xlife Sciences AG
Glance View
Xlife Sciences AG focuses on the value development of performance promising technologies in life sciences. The company is headquartered in Zurich, Zuerich and currently employs 19 full-time employees. The company went IPO on 2019-09-30. The firm focuses on investing in technologies in the life science industry. The company supports researchers and entrepreneurs in positioning, structuring, developing and implementing their concepts. The firm offers its investors direct access to the further development of technologies at a very early stage. The firm cooperates with industrial partners and universities.
